Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
---|
11/10/2004 | CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity |
11/10/2004 | CN1544088A Immediate release tablet |
11/09/2004 | US6814986 Composition for treating obesity and esthetic treatment process |
11/04/2004 | US20040220209 Novel imidazopyridine compounds with therapeutic effect |
11/04/2004 | US20040220162 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
11/04/2004 | US20040220157 a 3-oxoandrostrane carbothioic acid compound |
11/03/2004 | EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
11/03/2004 | CN1543464A Novel imidazopyridine compounds with therapeutic effect |
11/03/2004 | CN1173703C Pharmaceutical composition |
11/03/2004 | CN1173692C Cosmetic composition and method for reducing skin aging procedure |
11/02/2004 | US6812219 Methods and compositions for treating flaviviruses and pestiviruses |
10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
10/28/2004 | US20040214841 Quinazoline derivatives for treatment of tumours |
10/28/2004 | US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
10/28/2004 | US20040214793 In aitu applying to bone joints |
10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
10/27/2004 | CN1541225A Humanized antibodies that recognize beta amyloid peptide |
10/21/2004 | WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
10/21/2004 | US20040209922 Pyridine matrix metalloproteinase inhibitors |
10/21/2004 | CA2522023A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
10/20/2004 | EP1468686A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders |
10/20/2004 | EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
10/20/2004 | EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors |
10/20/2004 | EP1140941B1 Nitrogen containing heterobicycles as factor xa inhibitors |
10/13/2004 | EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
10/13/2004 | EP1257584B1 Humanized antibodies that sequester amyloid beta peptide |
10/13/2004 | EP1165069B1 Antitumour synergistic composition |
10/13/2004 | CN1537112A Pyrimidine compound |
10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
10/13/2004 | CN1537008A Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid |
10/13/2004 | CN1537007A 2 methyl-thieno-benzodiazepine lyophilizde formulation |
10/13/2004 | CN1170817C 前列腺素e类似物 E prostaglandin analogs |
10/07/2004 | US20040198787 Efficient process for the preparation of a factor Xa inhibitor |
10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
10/06/2004 | CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl} |
10/06/2004 | CN1535144A Pharmaceutical combination comprising either (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic aicd or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl) ethyoxy] phenyl} |
10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
09/29/2004 | EP1462442A1 Crystals of bicalutamide and process for their production |
09/29/2004 | EP0878199B1 Natural tea comprising alder and mountain ash extracts for treating the effects of alcoholic drinks |
09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
09/23/2004 | US20040185122 Selective COX-2 inhibition from edible plant extracts |
09/23/2004 | US20040185098 Making oral dosage form by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules |
09/22/2004 | EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
09/22/2004 | EP1458689A1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
09/22/2004 | EP1458376A1 Darifenacin for use in the treatment of urgency induced by overactive bladder |
09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
09/15/2004 | EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith |
09/15/2004 | EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
09/15/2004 | EP1173210B1 Contraceptive compositions containing antiprogestinic and progestinic |
09/15/2004 | CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
09/14/2004 | US6790850 Thiazolo(4,5-d)pyrimidine compounds |
09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
09/09/2004 | US20040176462 NPY Y5 antagonist |
09/09/2004 | US20040176357 Stable, amorphous , lyophilized, parenteral injections comprising olanzapine, solubilizer and stabilizer; bipolar, psychological and neurodegenerative disorders; anxiolytic agents;schizophrenia |
09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
09/08/2004 | CN1165310C Drug-(combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6- enoic acid and an inhibitor,inducer or substrate of P450 |
09/08/2004 | CN1165307C Controlled release oxycodone compositions |
09/08/2004 | CN1165299C Composition for treatment of psoriasis |
09/08/2004 | CN1165289C Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
09/07/2004 | US6787549 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder |
09/07/2004 | US6787535 Indole derivatives with 5HT6 receptor affinity |
09/02/2004 | WO2004074262A1 Hiv replication inhibiting pyrimidines and triazines |
09/02/2004 | WO2004074261A1 Hiv replication inhibiting pyrimidines and triazines |
09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
09/02/2004 | WO2003099786A3 Aromatic sulfones and their medical use |
09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
09/01/2004 | EP1450834A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
09/01/2004 | EP1292594B1 Quinazoline derivatives for the treatment of tumours |
09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
08/25/2004 | EP1448201A2 Use of n-(indolcarbonyl-)piperazine derivatives |
08/25/2004 | EP1448182A1 Pharmaceutical compositions and methods for administering ep 2 receptor selective agonists |
08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
08/24/2004 | US6780879 As antitumor agent |
08/18/2004 | EP1446131A1 Use of specific dose of fondaparinux sodium for the treatment of acs |
08/18/2004 | EP1446123A1 Rosuvastatin in pre demented states |
08/18/2004 | EP1446122A1 Use of flibanserin in the treatment of sexual disorders |
08/17/2004 | US6777543 13-methyl erythromycin derivatives |
08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
08/12/2004 | WO2004045718A3 Treatment of cognitive dysfunctions' |
08/12/2004 | US20040157927 Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea |
08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
08/11/2004 | EP1443945A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |